The 1 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +367.29% increase from the last price of 2.14.
The current consensus among 1 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.11
Reporting Date Feb 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.